mounjaro tirzepatide injection MHRA grants authorisation for Lilly's weight loss drug dependent insulinotropic polypeptide (GIP) and glucagon Mounjaro Injection (Tirzepatide) for Diabetes

(2012) www.sciencedaily.com From the article: We were surprised to observe a 50 percent reduction in testosterone in this pediatric study because these obese males were young and were not diabetic , says Paresh Dandona, MD, PhD, SUNY Distinguished Professor in the Department of Medicine, chief of the Division of Endocrinology, Diabetes and Metabolism in the UB medical school and first author on the study

Suitability depends on medical evaluation

Tirzepatide is not recommended for weight loss during pregnancy, and the medication should be discontinued if pregnancy occurs

De-escalation strategies may include a dose reduction or a lengthening of the drug administration intervals while maintaining the same clinical effects